Ligand to Present at the Roth Capital Partners 17th Annual Growth Stock Conference.DANA POINT, Calif. -- Ligand (Nasdaq:LGND LGND Luminance Ground ) will be presenting on Tuesday, February 22, 2005, at the Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, 17th Annual Growth Stock Conference. The presentation web cast may be accessed live at www.ligand.com, in the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of the site, under "Current Presentations." The presentation will be archived on Ligand's site for 30 days. About Ligand Ligand discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription Gene transcription The process by which genetic information is copied from DNA to RNA, resulting in a specific protein formation. Mentioned in: Gene Therapy technology, primarily related to Intracellular Receptors. For more information, go to www.ligand.com. About the Roth Capital Partners 17th Annual Growth Stock Conference This conference will feature more than 220 leading growth companies in sectors such as Technology, Healthcare, Financial Services The examples and perspective in this article or section may not represent a worldwide view of the subject. Please [ improve this article] or discuss the issue on the talk page. and Consumer Products. A concentrated, two-day program will allow institutional investors to meet the executives from a select group of companies that have been hand picked by the Roth Capital Partners research team. 40% of this year's participating companies are presenting here for the first time. The average market cap of this year's presenters is around $330 million, with the median around $185 million. This closely mirrors the average and median market cap Median market cap The midpoint of market capitalization (market price multiplied by the number of shares outstanding) of the stocks in a portfolio. Half the stocks in the portfolio will have higher market capitalizations; half will have lower. for the proposed Russell Microcap microcap 1. Of or relating to the common stock of a company with a small capitalization, usually between $50 million and $250 million. Microcap stocks tend to experience volatile price movements and are subject to investment fraud schemes. (TM) Index which is expected to be around $277 million and $176 million respectively. To register for this conference, please contact your Roth sales representative at 800-678-9147. Please note that this conference is by invitation only. For more information about the conference visit: http://www.rothcp.com/2005%20DP%20Conference%20Web%20Site /Roth%20DP.html?content=home. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion